Zoetis Operating Income 2012-2025 | ZTS

Zoetis annual/quarterly operating income history and growth rate from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Zoetis operating income for the quarter ending September 30, 2025 was $887M, a 1.49% increase year-over-year.
Zoetis operating income for the twelve months ending September 30, 2025 was $3.331B, a 9.18% increase year-over-year.
Zoetis annual operating income for 2024 was $3.133B, a 6.71% increase from 2023.
Zoetis annual operating income for 2023 was $2.936B, a 10.54% increase from 2022.
Zoetis annual operating income for 2022 was $2.656B, a 6.75% increase from 2021.

Zoetis Annual Operating Income (Millions of US $)
2024	$3,133
2023	$2,936
2022	$2,656
2021	$2,488
2020	$1,996
2019	$1,801
2018	$1,690
2017	$1,525
2016	$1,228
2015	$545
2014	$820
2013	$690
2012	$710
2011	$394

Zoetis Quarterly Operating Income (Millions of US $)
2025-09-30	$887
2025-06-30	$902
2025-03-31	$810
2024-12-31	$732
2024-09-30	$874
2024-06-30	$780
2024-03-31	$747
2023-12-31	$650
2023-09-30	$717
2023-06-30	$872
2023-03-31	$697
2022-12-31	$592
2022-09-30	$667
2022-06-30	$670
2022-03-31	$727
2021-12-31	$506
2021-09-30	$659
2021-06-30	$636
2021-03-31	$687
2020-12-31	$420
2020-09-30	$597
2020-06-30	$482
2020-03-31	$497
2019-12-31	$437
2019-09-30	$528
2019-06-30	$455
2019-03-31	$381
2018-12-31	$418
2018-09-30	$418
2018-06-30	$437
2018-03-31	$417
2017-12-31	$430
2017-09-30	$413
2017-06-30	$345
2017-03-31	$337
2016-12-31	$231
2016-09-30	$333
2016-06-30	$332
2016-03-31	$332
2015-12-31	$69
2015-09-30	$273
2015-06-30	$-27
2015-03-31	$230
2014-12-31	$155
2014-09-30	$238
2014-06-30	$200
2014-03-31	$227
2013-12-31	$126
2013-09-30	$185
2013-06-30	$187
2013-03-31	$192
2012-12-31	$82
2012-09-30	$213
2012-06-30	$252
2012-03-31	$171
2011-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$56.043B	$9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$89.187B	33.88
Takeda Pharmaceutical (TAK)	Japan	$51.898B	10.59
Daiichi Sankyo, - (DSNKY)	Japan	$43.551B	21.69
BeOne Medicines - (ONC)	Switzerland	$37.054B	196.45
Sandoz Group AG (SDZNY)	Switzerland	$33.348B	0.00
United Therapeutics (UTHR)	United States	$20.806B	18.31
Merck (MKKGY)	Germany	$19.348B	11.93
Shionogi (SGIOY)	Japan	$15.738B	14.45
Summit Therapeutics (SMMT)	United States	$15.176B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.539B	32.49
Ionis Pharmaceuticals (IONS)	United States	$13.007B	0.00
IPSEN (IPSEY)	France	$12.338B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.675B	0.00
Orion OYJ (ORINY)	Finland	$11.045B	31.56
Eisai (ESAIY)		$8.854B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.576B	20.00
Grifols, S.A (GRFS)	Spain	$6.442B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.378B	35.69
Crinetics Pharmaceuticals (CRNX)	United States	$5.053B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.431B	18.08
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.074B	19.34
Corcept Therapeutics (CORT)	United States	$3.945B	42.61
NewAmsterdam Pharma (NAMS)	Netherlands	$3.897B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.014B	0.00
Hypermarcas (HYPMY)	Brazil	$2.914B	20.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.793B	8.91
Dyne Therapeutics (DYN)	United States	$2.538B	0.00
Ocular Therapeutix (OCUL)	United States	$2.399B	0.00
Soleno Therapeutics (SLNO)	United States	$2.310B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.997B	23.67
Guardian Pharmacy Services (GRDN)	United States	$1.920B	36.98
Ardelyx (ARDX)	United States	$1.881B	0.00
Harrow (HROW)	United States	$1.733B	106.32
BioCryst Pharmaceuticals (BCRX)	United States	$1.559B	92.50
Enliven Therapeutics (ELVN)	United States	$1.543B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.440B	7.13
Relay Therapeutics (RLAY)	United States	$1.385B	0.00
Oruka Therapeutics (ORKA)	United States	$1.349B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.341B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.316B	0.00
Evotec AG (EVO)	Germany	$1.300B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.291B	0.00
Savara (SVRA)	United States	$1.182B	0.00
Cronos Group (CRON)	Canada	$1.025B	0.00
Xencor (XNCR)	United States	$0.992B	0.00
Theravance Biopharma (TBPH)	United States	$0.965B	40.51
Esperion Therapeutics (ESPR)	United States	$0.928B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.849B	0.00
Nektar Therapeutics (NKTR)	United States	$0.808B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.769B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.741B	6.62
ProKidney (PROK)	United States	$0.704B	0.00
Bioventus (BVS)	United States	$0.665B	13.61
Ironwood Pharmaceuticals (IRWD)	United States	$0.660B	15.61
Organogenesis (ORGO)	United States	$0.534B	0.00
Lyell Immunopharma (LYEL)	United States	$0.522B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.521B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.478B	0.00
Aquestive Therapeutics (AQST)	United States	$0.477B	0.00
Siga Technologies (SIGA)	United States	$0.473B	6.48
4D Molecular Therapeutics (FDMT)	United States	$0.429B	0.00
Altimmune (ALT)	United States	$0.419B	0.00
Akebia Therapeutics (AKBA)	United States	$0.403B	0.00
Nature's Sunshine Products (NATR)	United States	$0.380B	22.64
USANA Health Sciences (USNA)	United States	$0.363B	10.13
Relmada Therapeutics (RLMD)	United States	$0.316B	0.00
Avalo Therapeutics (AVTX)	United States	$0.314B	0.00
Profound Medical (PROF)	Canada	$0.306B	0.00
Protara Therapeutics (TARA)	United States	$0.297B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.296B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.286B	0.00
Larimar Therapeutics (LRMR)	United States	$0.276B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Fractyl Health (GUTS)	United States	$0.274B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.261B	0.00
Heron Therapeutics (HRTX)	United States	$0.255B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.247B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.214B	0.00
MediWound (MDWD)	Israel	$0.207B	0.00
Galectin Therapeutics (GALT)	United States	$0.203B	0.00
Journey Medical (DERM)	United States	$0.197B	0.00
Minerva Neurosciences (NERV)	United States	$0.193B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.188B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.170B	0.00
Prelude Therapeutics (PRLD)	United States	$0.165B	0.00
VAXART, INC (VXRT)	United States	$0.164B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
AleAnna (ANNA)	United States	$0.160B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.159B	0.00
Surrozen (SRZN)	United States	$0.158B	0.00
Context Therapeutics (CNTX)	United States	$0.148B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.146B	0.00
Incannex Healthcare (IXHL)	Australia	$0.137B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.133B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.129B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Pyxis Oncology (PYXS)	United States	$0.110B	0.00
Avita Medical (RCEL)	United States	$0.104B	0.00
Cassava Sciences (SAVA)	United States	$0.101B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.099B	0.00
Vivani Medical (VANI)	United States	$0.097B	0.00
Champions Oncology (CSBR)	United States	$0.094B	39.88
Korro Bio (KRRO)	United States	$0.089B	0.00
Gain Therapeutics (GANX)	United States	$0.089B	0.00
Plus Therapeutics (PSTV)	United States	$0.076B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.074B	61.88
PolyPid (PYPD)	Israel	$0.074B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Metagenomi (MGX)	United States	$0.067B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.066B	0.00
Arch Biopartners (ACHFF)	Canada	$0.064B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.063B	0.00
Assertio Holdings (ASRT)	United States	$0.059B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.055B	0.00
Lite Strategy (LITS)	United States	$0.054B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Talphera (TLPH)	United States	$0.049B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.047B	0.00
ElectroCore (ECOR)	United States	$0.045B	0.00
Lipocine (LPCN)	United States	$0.044B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.039B	0.00
FibroGen (KYNB)	United States	$0.037B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Wellgistics Health (WGRX)	United States	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.033B	0.00
SCYNEXIS (SCYX)	United States	$0.028B	0.00
Natural Alternatives (NAII)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Klotho Neurosciences (KLTO)	United States	$0.025B	0.00
Scienture Holdings (SCNX)	United States	$0.023B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Cosmos Health (COSM)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
Tempest Therapeutics (TPST)	United States	$0.014B	0.00
CASI Pharmaceuticals (CASI)	China	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Traws Pharma (TRAW)	United States	$0.011B	0.01
Curanex Pharmaceuticals Inc (CURX)	United States	$0.011B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
BioVie (BIVI)	United States	$0.010B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Lyra Therapeutics (LYRA)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Salarius Pharmaceuticals (DCOY)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Jaguar Animal Health (JAGX)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00